Login to Your Account

BIO 2013

New Partnerships Sought to Innovate Drug Development

By Marie Powers
Staff Writer

Thursday, April 25, 2013
CHICAGO – Innovation was the topic of a heavily attended supersession at BIO 2013 that featured presenters from big pharma, academia, federal agencies and the venture capital (VC) community but, interestingly, no biotechs.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription